World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
29865
World Ranking
13578
National Ranking
726

Overview

Andreas Reiter is affiliated with Heidelberg University in Germany and has contributed extensively to the field of medicine, focusing on immunology and microbiology. Their research spans several subfields including rheumatology, immunology, genetics, hematology, and physiology.

The primary research topics covered by Reiter include:

  • Eosinophilic Disorders and Syndromes
  • Mast cells and histamine
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Eosinophilic Esophagitis
  • Urticaria and Related Conditions
  • Asthma and respiratory diseases

Reiter has published numerous papers in reputable scientific venues. Examples of recent publications include:

  • New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis, 2020, Blood
  • Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia, 2022, Blood
  • Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial, 2021, Nature Medicine
  • Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes, 2022, Allergy
  • Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis, 2021, Journal of Clinical Oncology

Frequent co-authors in Reiter's collaborative work include:

  • Jason Gotlib
  • Juliana Schwaab
  • Alessandro M. Vannucchi
  • Deepti Radia
  • Tracy I. George

The most common publication venues where Reiter's work appears are:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Leukemia
  • The Journal of Allergy and Clinical Immunology In Practice
  • HemaSphere

Reiter's extensive research output includes 227 publications categorized primarily under Medicine and 63 under Immunology and Microbiology. Within specialized subfields, Reiter has contributed 77 publications to Rheumatology, 63 to Immunology, 52 to Genetics, 39 to Hematology, and 14 to Physiology. This reflects a broad and interdisciplinary approach to medical science, focusing on immune-related conditions and hematologic diseases.

Best Publications

  • Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

    Thomas Ernst;Andrew J Chase;Andrew J Chase;Joannah Score;Joannah Score;Claire E Hidalgo-Curtis;Claire E Hidalgo-Curtis

  • Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

    Amy V. Jones;Sebastian Kreil;Katerina Zoi;Katherine Waghorn

  • Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

    Tiziano Barbui;Giovanni Barosi;Gunnar Birgegard;Francisco Cervantes

  • Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes.

    Peter Valent;Amy D. Klion;Hans-Peter Horny;Florence Roufosse

  • Mutations and prognosis in primary myelofibrosis

    Alessandro Maria Vannucchi;Tl Lasho;Paola Guglielmelli;Flavia Biamonte

  • Philadelphia chromosome-negative classical myeloproliferative neoplasms: Revised management recommendations from European LeukemiaNet

    Tiziano Barbui;Ayalew Tefferi;Alessandro M. Vannucchi;Francesco Passamonti

  • Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis

    Jason Gotlib;Hanneke C. Kluin-Nelemans;Tracy I. George;Cem Akin

  • Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

    Robyn M. Emanuel;Amylou C. Dueck;Holly L. Geyer;Jean Jacques Kiladjian

  • JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms.

    Amy V Jones;Andrew Chase;Richard T Silver;David Oscier

  • Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms.

    Francis H. Grand;Claire E. Hidalgo-Curtis;Thomas Ernst;Katerina Zoi

  • Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR.

    M. Emig;S. Saussele;H. Wittor;A. Weisser

  • Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology

    Karin Hartmann;Luis Escribano;Clive Grattan;Knut Brockow

  • Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV

    Alice Fabarius;Armin Leitner;Andreas Hochhaus;Martin C. Müller

  • The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2

    Andreas Reiter;Christoph Walz;Ann Watmore;Claudia Schoch

  • DNA Topoisomerase II in Therapy-Related Acute Promyelocytic Leukemia

    Anita R. Mistry;Carolyn A. Felix;Ryan J. Whitmarsh;Annabel Mason

  • The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients.

    Paola Guglielmelli;Terra L. Lasho;Giada Rotunno;Joannah Score

  • Comprehensive mutational profiling in advanced systemic mastocytosis

    Juliana Schwaab;Susanne Schnittger;Karl Sotlar;Christoph Walz

  • The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1.

    Donald Macdonald;Andreas Reiter;Nicholas C.P. Cross

  • EZH2 mutational status predicts poor survival in myelofibrosis

    Paola Guglielmelli;Flavia Biamonte;Joannah Score;Joannah Score;Claire Hidalgo-Curtis;Claire Hidalgo-Curtis

  • Inactivating mutations of the histone methyltransferase EZH2 in myeloid disorders

    T Ernst;A Chase;J Score;C Hidalgo-Curtis

Frequent Co-Authors

Nicholas C.P. Cross
Nicholas C.P. Cross University of Southampton
Andreas Hochhaus
Andreas Hochhaus Friedrich Schiller University Jena
Peter Valent
Peter Valent Medical University of Vienna
Jason Gotlib
Jason Gotlib Stanford University
Karin Hartmann
Karin Hartmann University Hospital of Basel
Torsten Haferlach
Torsten Haferlach MLL Munich Leukemia Laboratory
Alessandro M. Vannucchi
Alessandro M. Vannucchi University of Florence
Hanneke C. Kluin-Nelemans
Hanneke C. Kluin-Nelemans University Medical Center Groningen
Rüdiger Hehlmann
Rüdiger Hehlmann Heidelberg University
Francisco Cervantes
Francisco Cervantes University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers but exploring more flexible or alternative pathways, there are several accredited online options worth considering. Many registered nurses look to advance their qualifications affordably through average cost of rn to bsn programs. Research shows that online RN to BSN programs can be both budget-friendly and accessible for working professionals.

If you have a non-nursing background and want to make a direct transition into nursing, several direct msn programs online offer an accelerated route. These programs are structured to get you into the workforce faster—often in as little as 18 months.

Additionally, students may benefit from researching the easiest nursing schools to get into to maximize their chances of admission and quickly start their education journey.

For those interested in the administrative side of healthcare, medical billing and coding schools that accept financial aid are another pathway offering online flexibility and a growing job market—all while making education more financially accessible.

Best Scientists Citing Andreas Reiter

Trending Scientists

Recently Published Articles